Bioctogen Boston Corporation is a Biotech CRO offering Immuno-Oncology drug validation services that rely on independently-developed humanized immune-checkpoint mouse models (e.g. B-hPD-1 mice) and immune-deficient, human immune system-reconstituted mice (B-NDG model). Biocytogen also offers antibody humanized mouse models, CDX models, PDX models, in vivo services, PK/PD services, ect. All models are generated by our custom gene targeting platform, featuring CRISPR-based EGE® technology, which increases large fragment knockin efficiency by 10-20-fold. Learn more at www.biocytogen.com.
Myriad RBM, Inc. is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services. Myriad RBM’s internally developed and manufactured immunoassay kits based on Multi-Analyte Profiling (MAP) and ultrasensitive Single-Molecule Array (SimoaTM) technology, provide reproducible and quantitative data for hundreds of human proteins.
TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.
NEBION provides scientists and biomedical researchers with GENEVESTIGATOR®, the premier application for the meta-analysis of public and private gene expression data. Users particularly appreciate the high quality of curated data in combination with the intuitive data mining tools, which they use for the identification and characterization of novel biomarkers and drug targets, prediction of side effects and drug repurposing. Besides the constant expansion and development of GENEVESTIGATOR®, NEBION offers transcriptomics data curation and analysis services.
Flagship Biosciences, Inc. is a technology driven tissue analysis services company delivering the most accurate and informative data for improved drug development. The company offers a full range of tissue analysis services using its award-winning technology to deliver breakthrough contextual data supported by a team of experienced pathology and scientific experts. It caters to pharmaceutical, biotechnology, and clinical diagnostic companies. Flagship Biosciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado. www.flagshipbio.com
PromoCell is the premier manufacturer of cell culture products. PromoCell offers broad range of human primary cells, stem cells and blood cells, optimized cell culture media, and a comprehensive line of cell biology research products. Our cell culture products provide scientists with physiologically accurate models, and therefore enable them to obtain better research results. As the original manufacturer, PromoCell is committed to the highest possible ethical and legal standards
Alloplex Biotherapeutics is a privately held Boston based cellular therapeutics company. Our lead oncology program uses proprietary leukocyte activator cell (LAC) lines, which are engineered from a common tumor cell line to express an array of immunomodulatory ligands designed to specifically engage and activate various components of peripheral blood mononuclear cells (PBMC) through their native receptors. These therapeutic cells have both high potency and tumor specificity. A clinical trial is planned to begin in mid-2020.
HistologiX is a GCP accredited CRO based in the UK. They provide a full range of high quality Histopathology, IHC and Image Analysis services to support Pre-clinical and Clinical R&D, Immuno-oncology and biomarker research. With extensive experience in custom IHC assay development, HistologiX offer brightfield and fluorescent, single or multiplex assay optimisation and validation, and can provide digital image analysis using a wide range of algorithms from the HALO image analysis suite.
GenScript is the world leader in biotechnology reagent and biologics service industry. Established in 2002 in New Jersey, the company was the first to commercialize gene synthesis and successfully establish fully integrated capabilities for peptide synthesis, protein expression and antibody development. GenScript also have integrated & innovative biologics CDMO platform to accelerate the process from target to market and drive innovation further to develop therapeutic antibody and cell therapy platforms. We provide Antibody Discovery, Development services including plasmid and viral vectors. Our mission is making people and nature healthier through biotechnology.